Unlike animals, plants do not possess an adaptive immune system with antibodies or T cells to fight viral infections. Instead ...

Airna will use the Series B round to launch a Phase 1/2 trial of its lead program for alpha-1 antitrypsin deficiency, a ...

Before a prostate biopsy is performed, various preliminary screening procedures are typically conducted. These include a ...

AIRNA’s lead candidate AIR-001 works by correcting the most common pathologic mutation driving the rare disease alpha-1 ...

Flagship Pioneering-backed Sail Biomedicines has laid off 12 employees following a review of the company’s organizational ...

Aqemia announces it is broadening and accelerating its computational platform to target RNAs using its physics-enabled ...

There is an urgent need for precision immunotherapy strategies that simultaneously target both tumor cells and immune cells ...

Fungal infections are on the rise globally. According to a study by the Manchester Fungal Infection Group, in 2022, ...

RNA-based therapeutics are gaining traction due to advancements in delivery technologies, despite historical challenges with ...

Korro Bio's OPERA platform offers precise RNA editing for genetic diseases like Alpha-1 antitrypsin deficiency. Learn more on ...

CHICAGO — Lepodisiran, a small interfering RNA agent, lowered lipoprotein(a) levels at 180 days, with a reduction of more ...

Two molecular control factors play a decisive role in what is known as splicing, the cutting and assembly of mature messenger ...